Key result
This review provides an overview of the pathophysiology of venous thromboembolism and current prevention guidelines, including the use of aspirin for prophylaxis in orthopaedic surgery patients.
This article provides an overview of VTE pathophysiology and current prevention guidelines, highlighting the use of aspirin for low-risk orthopaedic surgery patients.
May inform low-risk orthopaedic VTE prophylaxis choices; leaves open need for updated RCTs before practice change.
Venous thromboembolism (VTE) is a term used collectively for deep vein thrombosis (DVT) and pulmonary embolism. Without prophylaxis, the incidence of documented DVT in the orthopaedic surgery patient is reported in the range of 50%-60%. A multimodal approach to DVT prophylaxis is the standard of care for all patients undergoing total hip arthroplasty and total knee arthroplasty. At our local hospital, low-risk patients are being sent home with aspirin as the medication for VTE prophylaxis. This article will provide an overview of the pathophysiology of VTE and the current prevention guidelines including the use of aspirin.
No takes yet. Share an insight, caveat, or question.
Brenda K. Snyder (2008) conducted a review in Venous thromboembolism (VTE) in orthopaedic surgery. Aspirin was evaluated. This review provides an overview of the pathophysiology of venous thromboembolism and current prevention guidelines, including the use of aspirin for prophylaxis in orthopaedic surgery patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: